Holding(s) in Company
09 janv. 2019 11h45 HE
|
Summit Therapeutics plc
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...
Update on Admission
08 janv. 2019 02h00 HE
|
Summit Therapeutics plc
Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) Subscription to Raise $25m Oxford, UK, and Cambridge, MA, US, 8 January 2019 - Summit Therapeutics (AIM: SUMM, NASDAQ: SMMT), a...
Result of General Meeting
04 janv. 2019 07h30 HE
|
Summit Therapeutics plc
Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) Result of General Meeting Oxford, UK, and Cambridge, MA, US, 4 January 2019 - Summit Therapeutics (AIM: SUMM, NASDAQ: SMMT), a...
Holding(s) in Company
02 janv. 2019 04h40 HE
|
Summit Therapeutics plc
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...
Holding(s) in Company
18 déc. 2018 07h15 HE
|
Summit Therapeutics plc
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...
Proposed Subscription to Raise $25m and Notice of General Meeting
17 déc. 2018 02h05 HE
|
Summit Therapeutics plc
THIS ANNOUNCEMENT (INCLUDING THE APPENDICES) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, OR...
Summit Therapeutics Announces Departure of Chief Financial Officer
17 déc. 2018 02h00 HE
|
Summit Therapeutics plc
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Therapeutics Announces Departure of Chief Financial Officer Oxford, UK, and Cambridge, MA, US, 17 December 2018 - Summit Therapeutics plc...
3rd Quarter Results
11 déc. 2018 07h00 HE
|
Summit Therapeutics plc
Summit Therapeutics plc(‘Summit’, the ‘Company’ or the ‘Group’) Summit Therapeutics Reports Financial Results for the Third Quarter and Nine Months Ended 31 October 2018 and Operational Progress ...
Summit Therapeutics to Report Financial Results for the Third Quarter and Nine Months Ended 31 October 2018 on 11 December 2018
06 déc. 2018 07h00 HE
|
Summit Therapeutics plc
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Therapeutics to Report Financial Results for the Third Quarter and Nine Months Ended 31 October 2018 on 11 December 2018 Oxford,...
Holding(s) in Company
30 nov. 2018 08h30 HE
|
Summit Therapeutics plc
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...